-
AKBA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Akebia Therapeutics (AKBA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 35.69 mm | 35.69 mm | 35.69 mm | 35.69 mm | 35.69 mm | 35.69 mm |
Cash burn (monthly) | 1.82 mm | 1.04 mm | 6.68 mm | 3.78 mm | 2.23 mm | 3.21 mm |
Cash used (since last report) | 7.34 mm | 4.18 mm | 26.87 mm | 15.21 mm | 8.98 mm | 12.90 mm |
Cash remaining | 28.35 mm | 31.51 mm | 8.83 mm | 20.48 mm | 26.72 mm | 22.79 mm |
Runway (months of cash) | 15.5 | 30.3 | 1.3 | 5.4 | 12.0 | 7.1 |
13F holders | Current |
---|---|
Total holders | 116 |
Opened positions | 27 |
Closed positions | 15 |
Increased positions | 31 |
Reduced positions | 25 |
13F shares | Current |
---|---|
Total value | 77.50 bn |
Total shares | 59.43 mm |
Total puts | 179.40 k |
Total calls | 291.00 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 15.20 mm | $20.06 bn |
Vanguard | 10.07 mm | $13.29 bn |
Satter Management | 5.75 mm | $7.59 bn |
Geode Capital Management | 4.75 mm | $6.28 bn |
Renaissance Technologies | 3.72 mm | $4.91 bn |
STT State Street | 3.43 mm | $4.53 bn |
Jacobs Levy Equity Management | 2.03 mm | $2.69 bn |
NTRS Northern Trust | 1.64 mm | $2.16 bn |
Qube Research & Technologies | 1.32 mm | $1.75 bn |
MS Morgan Stanley | 1.09 mm | $1.44 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 25 | Ron Frieson | Common Stock | Option exercise | Acquire M | No | No | 0.45 | 20,100 | 9.05 k | 93,800 |
17 Jan 25 | Ron Frieson | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.45 | 20,100 | 9.05 k | 0 |
28 Jun 24 | Erik Ostrowski | Common Stock | Grant | Acquire A | No | No | 0 | 350,000 | 0.00 | 350,000 |
28 Jun 24 | Erik Ostrowski | Stock Option Common Stock | Grant | Acquire A | No | No | 1.02 | 500,000 | 510.00 k | 500,000 |
6 Jun 24 | Ron Frieson | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 73,700 |
6 Jun 24 | Ron Frieson | Stock Option Common Stock | Grant | Acquire A | No | No | 1.07 | 45,000 | 48.15 k | 45,000 |
6 Jun 24 | Adams Adrian | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 164,800 |
6 Jun 24 | Adams Adrian | Stock Option Common Stock | Grant | Acquire A | No | No | 1.07 | 45,000 | 48.15 k | 45,000 |